What is the recommended dosage of Atarax (hydroxyzine) for adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Atarax (Hydroxyzine) Dosage for Adults

For adults with anxiety and tension, the recommended dose is 50-100 mg four times daily (q.i.d.), while for pruritus from allergic conditions like chronic urticaria, the dose is 25 mg three to four times daily. 1

Standard Adult Dosing by Indication

Anxiety and Tension Relief

  • 50-100 mg four times daily (q.i.d.) for symptomatic relief of anxiety and tension associated with psychoneurosis or as adjunct therapy in organic disease states where anxiety manifests 1
  • Clinical studies demonstrate efficacy at 50 mg/day for generalized anxiety disorder, with significant reduction in Hamilton Anxiety Scale scores compared to placebo 2, 3
  • Anxiolytic effects typically begin within the first week of treatment and are maintained throughout the treatment period 3

Pruritus Management

  • 25 mg three to four times daily (t.i.d. or q.i.d.) for management of pruritus due to allergic conditions including chronic urticaria, atopic dermatitis, and contact dermatoses 1
  • This lower dose is specifically recommended for histamine-mediated pruritus 1
  • May be used as adjunctive therapy for opioid-induced pruritus in cancer patients, particularly when rotating from opiates to synthetic opioids is not feasible 4

Sedation/Premedication

  • 50-100 mg as premedication before procedures or following general anesthesia 1
  • When initiated via intramuscular route, subsequent doses may be administered orally 1

Critical Dosing Considerations

Elderly Patients

  • Lower doses are strongly recommended due to increased risk of anticholinergic effects, sedation, and cognitive impairment 5
  • The long half-life of 20 ± 4.1 hours increases risk of drug accumulation with repeated dosing in elderly patients 5
  • Higher doses significantly increase anticholinergic side effects, particularly problematic in patients with prostatic hypertrophy, elevated intraocular pressure, or baseline cognitive impairment 5

Renal Impairment

  • Dose should be halved in patients with moderate to severe renal impairment 4
  • Hydroxyzine should be avoided in severe renal impairment (creatinine clearance < 10 mL/min) 4

Hepatic Impairment

  • Avoid in severe liver disease as sedating effects are inappropriate and may precipitate complications 4

Safety and Tolerability Profile

Common Side Effects

  • Transient drowsiness/sleepiness occurs in 28-36% of patients, typically appearing during the first week and progressively diminishing with continued treatment 6, 3
  • Anticholinergic effects including dry mouth (14%) and blurred vision, particularly concerning in elderly patients 5, 6
  • Weight gain (12%), weakness (18%), and headache (6%) reported in clinical trials 6

Contraindications and Precautions

  • Contraindicated in early pregnancy, particularly first trimester, as it is the only antihistamine specifically contraindicated during early pregnancy stages 4
  • Should be avoided during lactation when possible 4
  • Discontinue at least 6 days before skin prick testing due to antihistaminic effects 4

Dose Adjustment Strategy

Dosage should be adjusted according to individual patient response to therapy 1. The evidence supports starting at standard doses and titrating based on:

  • Clinical efficacy in symptom control
  • Tolerability of side effects, particularly sedation
  • Patient-specific factors including age, renal function, and hepatic function
  • Concomitant medications that may interact or potentiate sedation

Duration of Treatment

  • For anxiety disorders, studies demonstrate maintained efficacy over 12 weeks without rebound anxiety or withdrawal symptoms upon abrupt discontinuation 2
  • Treatment duration should be determined by clinical response and underlying condition being treated 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Hydroxyzine Dosing and Safety Considerations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Atarax in treatment of anxiety in outpatient clinic].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.